Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally ,
Maingon P et al Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study, Ann Oncol, vol.11, pp.2205-2215, 2014. ,
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer, Journal of Clinical Oncology, vol.30, issue.36, pp.4558-65, 2012. ,
DOI : 10.1200/JCO.2012.42.8771
Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation, Diseases of the Colon & Rectum, vol.59, issue.4, pp.264-273, 2016. ,
DOI : 10.1097/DCR.0000000000000543
Tailored Treatment Strategy for Locally Advanced Rectal Carcinoma Based on the Tumor Response to Induction Chemotherapy, Diseases of the Colon & Rectum, vol.60, issue.7, pp.653-663, 2017. ,
DOI : 10.1097/DCR.0000000000000849
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial, The Lancet, vol.390, issue.10093, pp.31056-31061, 2017. ,
DOI : 10.1016/S0140-6736(17)31056-5
Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer, Colorectal Dis, vol.6, pp.196-203, 2017. ,